1951
DOI: 10.1136/bmj.2.4726.259
|View full text |Cite
|
Sign up to set email alerts
|

Oral Hexamethonium Bromide in Essential Hypertension

Abstract: MIEDIC,AL JOURNAL followed up for periods varying from three months to two years, and, although it has not been possible to obtain follow-up blood pictures, in no cases have symptoms returned. DiscussionThe fact that these cases of anaemia are labelled idiopathic indicates that their aetiology is obscure. A combination of factors has probably rendered insufficient the amount of iron available for haemoglobin synthesis. It is less likely that there was an excessive iron loss by way of chronic' haemorrhage, alth… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1

Citation Types

0
4
0

Year Published

1951
1951
2021
2021

Publication Types

Select...
7
1
1

Relationship

0
9

Authors

Journals

citations
Cited by 29 publications
(4 citation statements)
references
References 8 publications
0
4
0
Order By: Relevance
“…It is proposed that adrenosterone, which is primarily responsible for reactivation of cortisol from cortisone, may be an inhibitor of the 11beta-hydroxysteroid dehydrogenase type 1 enzyme (11beta-HSD1) [40]. Hexamethonium bromide (enrichment value -0.813), a non-depolarizing ganglion blocker and an nAChR antagonist, can be used to treat hypertension and duodenal ulcers [41,42]. After reviewing the literature, we found that the effectiveness and safety of adrenosterone and hexamethonium bromide in thyroid cancer treatment have not been studied.…”
Section: Discussionmentioning
confidence: 99%
“…It is proposed that adrenosterone, which is primarily responsible for reactivation of cortisol from cortisone, may be an inhibitor of the 11beta-hydroxysteroid dehydrogenase type 1 enzyme (11beta-HSD1) [40]. Hexamethonium bromide (enrichment value -0.813), a non-depolarizing ganglion blocker and an nAChR antagonist, can be used to treat hypertension and duodenal ulcers [41,42]. After reviewing the literature, we found that the effectiveness and safety of adrenosterone and hexamethonium bromide in thyroid cancer treatment have not been studied.…”
Section: Discussionmentioning
confidence: 99%
“…Hexamethonium bromide is a non-depolarizing ganglion blocker and a (nicotinic acetylcholine receptors) nAChR antagonist. It can be used to treat hypertension and duodenal ulcers [48,49]. It is known to be poorly absorbed from the gastrointestinal tract and does not cross the blood-brain barrier.…”
Section: Resultsmentioning
confidence: 99%
“…Adverse views on the oral value of administration of methonium compounds have been given by Locket et al (1951), whereas in the hands of Mackey and Shaw (1951) and Campbell et al (1952) this method was effective. Kilpatrick and Smirk (1952) have found the oral route a useful substitute for injections, although the results were less predictable; oral therapy was more likely to be successful when the patient was sensitive to small subcutaneous dosage.…”
Section: Ganglion-blocking Agentsmentioning
confidence: 99%